About UsProductsNewsClinical TrialCorporate RelationsResources

Overview

Zuragen™ Injection

ZuraPrep™

Centros™

Pipeline

Ash Access Technology, Inc is committed to building a comprehensive product portfolio of specialty therapeutics and medical devices that will advance the care of patients requiring vascular access and infection control in the acute and chronic health care enviornments.

Currently there are six candidates in our product pipeline that are undergoing investigation.

Estimated Developmental Status as of Q3 2008
Product
Formulation
Pre-clinical FDA
Approved Safety Study
Pivotal PMA Trial
(AZEPTIC)
Zuragen™

 

Estimated Developmental Status as of Q3 2008
Product
Formulation
Human Pilot
Efficacy and Safety Studies
Pre-IND
Submission and Meeting
ZuraPrep™

 

Catheter Portfolio
Catheter Type
Prototype Development
Bench/ Clinical Testing

FDA 510(k)
Status
Centros™
LT* Tunneled Hemodialysis
Completed
Completed
Approved
June 2008
SureFlow™
LT Tunneled Hemodialysis
Completed
Ongoing
TBD
MaxFlow™
Peritoneal Dialysis
Completed
Ongoing
TBD
BaxCath™
Impregnation System
All Ash Catheters
Ongoing
Ongoing
TBD

*LT = long-term